Thalidomide attenuates learning and memory deficits induced by intracerebroventricular administration of streptozotocin in rats

Biotechnic and Histochemistry

Volumn 88, Issue 3-4, 2013, Pages 145-152

  Elcioglu H K ^a   Kabasakal, L ^a   Alan, S ^b   Salva E ^a   Tufan, F ^c   Karan, M A ^c  

^a MARMARA UNIVERSITY   (Turkey)

^b State Hospital   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Alzheimer; Streptozotocin; Thalidomide

Indexed keywords

NEUROPROTECTIVE AGENT; STREPTOZOCIN; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; NEUROFIBRILLARY TANGLE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ALZHEIMER DISEASE; ANIMALS; AVOIDANCE LEARNING; BRAIN; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAVENTRICULAR; LEARNING DISORDERS; MALE; MAZE LEARNING; MEMORY DISORDERS; NEUROFIBRILLARY TANGLES; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84876458324     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.3109/10520295.2012.744471     Document Type: Article

References (35)

1. Ahmad M, Saleem S, Ahmad AS, Yousuf S, Ansari MA, Khan MB, Ishrat T, Chaturvedi RK, Agrawal AK, Islam F (2005) Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine induced par-kinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J. Neurochem. 93: 94-104. (Pubitemid 40463519)
2. Akama KT, Van Eldik LJ (2000) Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta-and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor-and NFkappaB-inducing kinase-dependent signaling mech an ism. J. Biol. Chem. 275: 7918-7924. (Pubitemid 30159700)
3. Alkam T, Nitta A, Mizoguchi H, Saito K, Seshima M, Itoh A, Yamada K, Nabeshima T (2008) Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta induced impairment of recognition memory in mice. Behav. Brain Res. 189: 100-106.
4. Baratz R, Tweedie D, Rubovitch V, Luo W, Yoon JS, Hoffer BJ, Greig NH, Pick CG (2011) Tumor necrosis factor-α synthesis inhibitor, 3, 6 '-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice. J. Neurochem. 118: 1032-1042.
5. Beckman JS, Crow JP (1993) Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21: 330-334. (Pubitemid 23167917)
6. Belarbi K, Jopson T, Tweedie D, Arellano C, Luo W, Greig NH, Rosi S (2012) TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive def cits induced by chronic neuroinf ammation. J. Neuroinf am. 9: 1-13.
7. Blokland A, Jolles J (1993) Spatial learning def cit and reduced hippocampal ChAT activity in rats after an i.c.v. injection of streptozotocin. Pharmacol. Biochem. Behav. 44: 491-494.
8. Chan ED, Riches DW (1998) Potential role of the JNK/SAPK signal transduction pathway in the induction of iNOS by TNF-alpha. Biochem. Biophys. Res. Commun. 253: 790-796. (Pubitemid 29039221)
9. Clodfelder-Miller BJ, Zmijewska AA, Johnson GV, Jope RS (2006) Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin induced insulin defciency. Diabetes 55: 3320-3325. (Pubitemid 44923588)
10. Deng Y, Li B, Liu Y, Iqbal K, Grundke-Iqbal I, Gong CX (2009) Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neuroflaments in the brain: implication for Alzheimer's disease. Am. J. Pathol. 175: 2089-2098.
11. Grunblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S (2007) Brain insulin system in STZ ICV treated rats generates hyperphosphorylated tau protein. J. Neurochem. 101: 757-770.
12. Heneka MT, O'Banion MK, Terwel D, Kummer MP (2010) Neuroinf ammatory processes in Alzheimer's disease. J. Neural. Transm. 117: 919-947.
13. Huang YJ, Liao JF, Tsai TH (2005) Concurrent determination of thalidomide in rat blood, brain and bile using multiple microdialysis coupled to liquid chromatogra-phy. Biomed. Chromatogr. 19: 488-493.
14. Jicha GA, Carr SA (2010) Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease. J. Alzheimers Dis. 19: 253-272.
15. Koppal T, Drake J, Yatin S, Jordan B, Varadarajan S, Bettenhausen L, Butterfeld DA (1999) Peroxynitrite induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease. J. Neurochem. 72: 310-317. (Pubitemid 29013906)
16. Li Y, Powers C, Jiang N, Chopp M (1998) Intact, injured, necrotic and apoptotic cells after focal cerebral ischemia in the rat. J. Neurol. Sci. 156: 119-132. (Pubitemid 28186463)
17. Massoud F, Gauthier S (2010) Update on the pharmacological treatment of Alzheimer's disease. Curr. Neurophar-macol. 8: 69-80.
18. Mayer G, Nitsch R, Hoyer S (1990) Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res. 532: 91-100.
19. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11: 47-60. (Pubitemid 14088970)
20. Nakahara N, Iga Y, Mizobe F, Kawanishi G (1998) Effects of intracerebroventricular injection of AF64A on learning behaviors in rats. Jpn. J. Pharmacol. 48: 121-130.
21. Neugroschl J, Sano M (2010) Current treatment and recent clinical research in Alzheimer's disease. Mt. Sinai J. Med. 77: 3-16.
22. Ren WJ, Liu Y, Zhou LJ, Li W, Zhong Y, Pang RP, Xin WJ, Wei XH, Wang J, Zhu HQ, Wu CY, Qin ZH, Liu G, Liu XG (2011) Peripheral nerve injury leads to working memory def cits and dysfunction of the hippocampus by upregulation of TNF-α in rodents. Neuropsy-chopharmacology 36: 979-992.
23. Rodrigues L, Dutra MF, Ilha J, Biasibetti R, Quincozes-Santos A, Leite MC, Marcuzzo S, Achaval M, Goncalves CA (2010) Treadmill training restores spatial cognitive def cits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroven-tricular administration of streptozotocin. J. Neural Transm. 117: 1295-1305.
24. Rodriguez GB, Passos GF, Di Giunta G, Figueiredo CP, Rodrigues EB, Grumman Jr A, Medeiros R, Calixto JB (2007) Preventive and therapeutic anti-inf ammatory effects of systemic and topical thalidomide on endotoxin induced uveitis in rats. Exp. Eye Res. 84: 553-560. (Pubitemid 46210059)
25. Ryu JK, McLarnon JG (2008) Thalidomide inhibition of perturbed vasculature and glial-derived tumor necrosis factor-alpha in an animal model of infamed Alzheimer's disease brain. Neurobiol. Dis. 29: 254-266.
26. Saxena G, Bharti S, Kamat PK, Sharma S, Nath C (2010) Melatonin alleviates memory def cits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats. Pharmacol. Biochem. Behav. 94: 397-403.
27. Shalit F, Sredni B, Rosenblatt-Bin H, Kazimirsky G, Brodie C, Huberman M (1997) Beta-amyloid peptide induces tumor necrosis factor-alpha and nitric oxide production in murine macrophage cultures. Neuroreport 8: 3577-3580. (Pubitemid 27497486)
28. Sharma M, Gupta YK (2001) Effect of chronic treatment of melatonin on learning, memory and oxidative def cien-cies induced by intracerebroventricular streptozotocin in rats. Pharmacol. Biochem. Behav. 70: 325-331. (Pubitemid 33051001)
29. Sharma M, Gupta YK (2002) Chronic treatment with trans resveratrol prevents intracerebroventricular strep-tozotocin induced cognitive impairment and oxidative stress in rats. Life Sci. 71: 2489-2498. (Pubitemid 35251893)
30. Shi JQ, Shen W, Chen J, Wang BR, Zhong LL, Zhu YW, Zhu HQ, Zhang QQ, Zhang YD, Xu J (2011) Anti-TNF-alpha reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains. Brain Res. 1368: 239-247.
31. Tobinick E (2010) Perispinal etanercept: a new therapeutic paradigm in neurology. Exp. Rev. Neurother. 10: 985-1002.
32. Tobinick EL, Gross, H (2008) Rapid cognitive improvement in Alzheimer's disease following perispinal etaner-cept administration. J. Neuroinf am. 5: 1-10.
33. Tweedie D, Sambamurti K, Greig NH (2007) TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets. Curr. Alzheimer Res. 4: 378-385. (Pubitemid 47421968)
34. Weiss EM, Kohler CG, Vonbank J, Stadelmann E, Kemmler G, Hinterhuber H, Marksteiner J (2008) Impairment in emotion recognition abilities in patients with mild cognitive impairment, early and moderate Alzheimer disease compared with healthy comparison subjects. Am. J. Geriat. Psych. 16: 974-980.
35. Yang CH, Otsuka M, Ohama E (2003) An Immunohis-tochemical study of perivascular plaque in Alzheimer ' s disease and cerebral amyloid angiopathy. Yonago Acta Med. 46: 9-16. (Pubitemid 36417565)